from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1781c/malQ

LFCtreatmentdescriptionclass of inhibitor

0.181

Amikacinug/mL Amikacintranslation

0.101

Cap5-10ug/mL Capreomycintranslation

0.809

Rox10-50 ug/mL Roxithromycintranslation

-0.211

SM2-5 ug/mL Streptomycintranslation

0.710

Tet5-10 ug/mL Tetracyclinetranslation

-0.134

Rif0.2-5ug/mL Rifampicintranscription

-0.856

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.273

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.393

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.609

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.827

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.798

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.695

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.274

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.193

Nigericin50 uM Nigericinrespiration

1.060

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.763

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.430

menadione6-10 ug/mL Menadionerespiration

0.652

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.714

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.714

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.920

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.310

NRP_1Non-replicating persistence stage 1dosRassociated

-0.805

Amp0.2mg/mL AmpicillincellWall

-0.688

Cephalexin20-100 ug/mL CephalexincellWall

0.689

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.822

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.654

EMB10-20 ug/mL EthambutolcellWall

-0.681

Eta12-40 ug/mL EthionamidecellWall

-0.270

INH0.2-0.4 ug/mL IsoniazidcellWall

0.177

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.775

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.043

BZA0.12 mg/mL BenzamidearomaticAmides

-0.352

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.203

H2O24 mM hydrogen peroxideDNAdamaging

0.503

Levo10 ug/mL LevofloxacinDNAdamaging

-0.949

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.336

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.339

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.295

Antimycin12.5-50 ug/mL Antimycin A?

0.318

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.355

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.108

PA8240.2-2 ug/mL PA-824?

0.047

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.355

Verapamil50 uM Verapamil?

1.429

mercaptoethanol2 mM 2-Mercaptoethanol?

4.290

methoxatin10-20 ug/mL Methoxatin?